BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,540 | +0.4% | 3,137 | +26.3% | 0.00% | – |
| Q2 2023 | $156,988 | +28.7% | 2,484 | -8.4% | 0.00% | – |
| Q1 2023 | $121,967 | +4.7% | 2,711 | +1.9% | 0.00% | – |
| Q4 2022 | $116,534 | -34.9% | 2,660 | -2.2% | 0.00% | – |
| Q3 2022 | $179,000 | +55.7% | 2,719 | +19.0% | 0.00% | – |
| Q2 2022 | $115,000 | -92.9% | 2,285 | -91.0% | 0.00% | -100.0% |
| Q1 2022 | $1,628,000 | -52.6% | 25,495 | -20.5% | 0.00% | -50.0% |
| Q4 2021 | $3,435,000 | – | 32,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |